0001140361-17-007725.txt : 20170215 0001140361-17-007725.hdr.sgml : 20170215 20170215164143 ACCESSION NUMBER: 0001140361-17-007725 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170214 FILED AS OF DATE: 20170215 DATE AS OF CHANGE: 20170215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioRestorative Therapies, Inc. CENTRAL INDEX KEY: 0001505497 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 911835664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: (631) 760-8100 MAIL ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: Stem Cell Assurance, Inc. DATE OF NAME CHANGE: 20101110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Field Edward L. CENTRAL INDEX KEY: 0001435185 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37603 FILM NUMBER: 17615141 MAIL ADDRESS: STREET 1: C/O BIORESTORATIVE THERAPIES, INC. STREET 2: 40 MARCUS DRIVE, SUITE 1 CITY: MELVILLE STATE: NY ZIP: 11747 4 1 doc1.xml FORM 4 X0306 4 2017-02-14 0 0001505497 BioRestorative Therapies, Inc. BRTX 0001435185 Field Edward L. 40 MARCUS DRIVE MELVILLE NY 11747 0 1 0 0 President brtxDISC Division Option 9.20 2017-02-14 4 D 0 25000 D 2025-02-09 Common Stock 25000 0 D Option 4.7 2017-02-14 4 A 0 25000 A 2025-02-09 Common Stock 25000 25000 D Option 7 2017-02-14 4 D 0 25000 D 2025-09-04 Common Stock 25000 0 D Option 4.7 2017-02-14 4 A 0 25000 A 2025-09-04 Common Stock 25000 25000 D Option 3.73 2026-06-10 Common Stock 80000 80000 D The option vests to the extent of 8,334 shares on February 9, 2016 and 8,333 shares on each of February 9, 2017 and February 9, 2018. The option is exercisable to the extent of 8,334 shares on September 4, 2016 and 8,333 shares on each of September 4, 2017 and September 4, 2018. The option is exercisable to the extent of 26,667 shares on each of June 10, 2017 and June 10, 2018, and 26,666 shares on June 10, 2019. The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. /s/ Edward L. Field 2017-02-14